levodopa has been researched along with Chronic Progressive External Ophthalmoplegia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caetano, A; Meira, B; Pinto, M; Roque, R | 1 |
| Cai, H; Matsubara, S; Mukai, M; Nakano, I; Sasaki, H; Sugaya, K; Yabe, I | 1 |
| Holme, E; Melberg, A; Moslemi, AR; Oldfors, A | 1 |
1 review(s) available for levodopa and Chronic Progressive External Ophthalmoplegia
| Article | Year |
|---|---|
[Familial progressive external opthalmoplegia, parkinsonism and polyneuropathy associated with POLG1 mutation].
Topics: Aged; DNA Polymerase gamma; DNA-Directed DNA Polymerase; DNA, Mitochondrial; Female; Gene Deletion; Genes, Dominant; Humans; Levodopa; Male; Menopause, Premature; Mitochondrial Diseases; Muscular Diseases; Mutation; Ophthalmoplegia, Chronic Progressive External; Parkinsonian Disorders; Pedigree; Polyneuropathies; Syndrome | 2014 |
2 other study(ies) available for levodopa and Chronic Progressive External Ophthalmoplegia
| Article | Year |
|---|---|
Late-onset presentation of POLG1-associated mitochondrial disease.
Topics: Age of Onset; Aged; Antiparkinson Agents; Blepharoptosis; Disease Progression; DNA Polymerase gamma; Humans; Levodopa; Male; Mitochondrial Diseases; Ophthalmoplegia, Chronic Progressive External; Parkinsonian Disorders; Point Mutation; Treatment Outcome | 2019 |
Autosomal dominant progressive external ophthalmoplegia: distribution of multiple mitochondrial DNA deletions.
Topics: Antiparkinson Agents; Brain; Cerebral Cortex; DNA, Mitochondrial; Female; Genes, Dominant; Humans; Levodopa; Middle Aged; Muscle, Skeletal; Ophthalmoplegia, Chronic Progressive External; Parkinson Disease; Repetitive Sequences, Nucleic Acid; Sequence Deletion | 1999 |